Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.
2.

Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.

Ling BC, Wu J, Miller SJ, Monk KR, Shamekh R, Rizvi TA, Decourten-Myers G, Vogel KS, DeClue JE, Ratner N.

Cancer Cell. 2005 Jan;7(1):65-75.

3.

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E.

N Engl J Med. 2004 Jul 22;351(4):337-45.

4.
5.

Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss.

Chen S, Rio C, Ji RR, Dikkes P, Coggeshall RE, Woolf CJ, Corfas G.

Nat Neurosci. 2003 Nov;6(11):1186-93. Epub 2003 Oct 12.

PMID:
14555954
6.

Expression of angiogenic factors in neurofibromas.

Kawachi Y, Xu X, Ichikawa E, Imakado S, Otsuka F.

Exp Dermatol. 2003 Aug;12(4):412-7.

PMID:
12930297
7.

Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis.

Miller SJ, Li H, Rizvi TA, Huang Y, Johansson G, Bowersock J, Sidani A, Vitullo J, Vogel K, Parysek LM, DeClue JE, Ratner N.

Mol Cell Biol. 2003 Mar;23(6):2213-24.

8.

Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-kappaB signaling pathway with the anti-epidermal growth factor antibody IMC-C225.

Sclabas GM, Fujioka S, Schmidt C, Fan Z, Evans DB, Chiao PJ.

J Gastrointest Surg. 2003 Jan;7(1):37-43; discussion 43.

PMID:
12559183
9.
10.

Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model.

Li H, Velasco-Miguel S, Vass WC, Parada LF, DeClue JE.

Cancer Res. 2002 Aug 1;62(15):4507-13.

11.

Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms.

Perry A, Kunz SN, Fuller CE, Banerjee R, Marley EF, Liapis H, Watson MA, Gutmann DH.

J Neuropathol Exp Neurol. 2002 Aug;61(8):702-9.

PMID:
12152785
12.

Plexiform neurofibromas in NF1: toward biologic-based therapy.

Packer RJ, Gutmann DH, Rubenstein A, Viskochil D, Zimmerman RA, Vezina G, Small J, Korf B.

Neurology. 2002 May 28;58(10):1461-70. Review.

PMID:
12041525
13.

Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.

Karashima T, Sweeney P, Slaton JW, Kim SJ, Kedar D, Izawa JI, Fan Z, Pettaway C, Hicklin DJ, Shuin T, Dinney CP.

Clin Cancer Res. 2002 May;8(5):1253-64.

14.

Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF.

Science. 2002 May 3;296(5569):920-2.

15.
16.

Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.

Roberts RB, Min L, Washington MK, Olsen SJ, Settle SH, Coffey RJ, Threadgill DW.

Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1521-6. Epub 2002 Jan 29.

17.

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

Ciardiello F, Tortora G.

Clin Cancer Res. 2001 Oct;7(10):2958-70. Review.

18.

The EGF receptor family as targets for cancer therapy.

Mendelsohn J, Baselga J.

Oncogene. 2000 Dec 27;19(56):6550-65. Review.

19.

The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.

Mashour GA, Ratner N, Khan GA, Wang HL, Martuza RL, Kurtz A.

Oncogene. 2001 Jan 4;20(1):97-105.

20.

Cell signaling by receptor tyrosine kinases.

Schlessinger J.

Cell. 2000 Oct 13;103(2):211-25. Review. No abstract available.

Supplemental Content

Support Center